Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review

Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review

Objectives Vasoactive drugs have exhibited clinical efficacy in addressing pulmonary arterial hypertension, manifesting a significant reduction in morbidity and mortality. Pulmonary hypertension may complicate advanced interstitial lung disease (PH-ILD) and is associated with high rates of disabilit...

Full description

Bibliographic Details
Main Authors: Francesco Blasi, Stefano Aliberti, Antonio Voza, Gabriele Bongiovanni, Antonio Tonutti, Anna Stainer, Mattia Nigro, Dean L Kellogg, Anoop Nambiar, Andrea Gramegna, Marco Mantero, Francesco Amati
Format: Article
Language:English
Published: BMJ Publishing Group 2024-07-01
Series:BMJ Open Respiratory Research
Online Access:https://bmjopenrespres.bmj.com/content/11/1/e002161.full

Internet

https://bmjopenrespres.bmj.com/content/11/1/e002161.full

Similar Items